Skip to main content
NIH funding notice RFA-NS-22-001

Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed)

Closed on November 22, 2021.

Posted
August 6, 2021
Close date
November 22, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
3
1 new, 2 renewals
Median first-year cost
$2,091,032
$6,158,045 in all
Institutions
3
3 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. CLEVELAND CLINIC LERNER COM-CWRU1
  2. EMORY UNIVERSITY1
  3. MAYO CLINIC ROCHESTER1

Most frequent study sections

  1. Special Emphasis Panel (ZNS1 SRB-T (52))3
3 awards under RFA-NS-22-001 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2022Longitudinal Imaging Biomarkers of Prodromal DLB2U01NS100620-06Boeve, Bradley FKantarci, KejalMAYO CLINIC ROCHESTER, MNFirst-year cost $2,425,965Study section ZNS1
FY2022Dementia with Lewy Bodies Consortium2U01NS100610-06Galasko, Douglas RLeverenz, James BruceLopez, Oscar L.CLEVELAND CLINIC LERNER COM-CWRU, OHFirst-year cost $2,091,032Study section ZNS1
FY2022Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia1U01NS128433-01Levey, Allan ISeyfried, Nicholas ThomasEMORY UNIVERSITY, GAFirst-year cost $1,641,048Study section ZNS1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-NS-22-001: Biomarkers for the Lewy Body Dementias (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience